Manufacturer record
Athens Life Sciences Mauza Rampur Jattan: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Athens Life Sciences Mauza Rampur Jattan (Himachal Pradesh) were declared Not of Standard Quality between November 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Athens Life Sciences Mauza Rampur Jattan in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro- Resistant & Domperidone Prologed Release Capsules I.P. | CG26-0049RMfg 2026-03 · Exp 2028-02 | 01. ASSAY OF PANTOPRAZOLE SODIUM I.P. & DOMPERIDONE I.P. ? Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Amoxycillin & Potassium Clavulanate Tablets IP | TB24-0672DMfg 2024-10 · Exp 2026-09 | Assay of Amoxycillin and Clavulanic acid and Dissolution test for AmoxycillinAssay | DCL, TelanganaState lab | Jan 2026 |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules RABIVO-DSR | CG25-0039PMfg 2025-02 · Exp 2027-01 | The sample does not conform to claim with respect to The Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab | Dec 2025 |
| Levocetirizine & Montelukast Tablets IP | TGT25-156Mfg 2025-07 · Exp 2027-06 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua Jammu and KashmirState lab | Dec 2025 |
| Ramipril Tablets IP 5 mg | TGT25-165Mfg 2025-07 · Exp 2027-06 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab | Nov 2025 |
| Methylprednisolone Tablets IP 4mg | TGT25-091Mfg 2025-04 · Exp 2027-03 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab | Nov 2025 |
| Ketorolac Tromethamine Tablets IP 10mg | TGT25-096Mfg 2025-04 · Exp 2027-03 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab | Nov 2025 |
| Glimepiride Tablets IP 2mg | TGT25-090Mfg 2025-04 · Exp 2027-03 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab | Nov 2025 |
| Deflazacort Tablets | TGT25-092Mfg 2025-04 · Exp 2027-03 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.